NASDAQ:AVTX | EBITDA | Avalo Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$20.88M
2025-12-31-$19.73M
2025-03-31-$14.53M
2024-12-31-$13.24M
2024-03-31-$32.73M
2023-12-31-$7.62M
2023-03-31-$8.76M
2022-12-31-$8.82M
2022-03-31-$20.79M
2021-12-31-$17.67M
2021-03-31-$30.13M
2020-12-31-$15.8M
2020-03-31-$30.96M
2019-12-31-$5.11M
2019-03-31-$3.91M
2018-12-31-$336,465.00
2018-03-31-$2.73M
2017-12-31-$3.95M
2017-03-31-$1.89M

Annual EBITDA

DateEBITDA
2025-12-31-$72.58M
2024-12-31-$68.34M
2023-12-31-$27.19M
2022-12-31-$37.27M
2021-12-31-$80.48M
2020-12-31-$71M
2019-12-31-$12.25M
2018-12-31-$30.82M
2017-12-31$14.32M
2016-12-31-$16.05M
2015-12-31-$10.99M